VBIZF
Price
$0.32
Change
-$0.01 (-3.12%)
Updated
Aug 26 closing price
Capitalization
757.19M
ZLDAF
Price
$0.23
Change
-$0.06 (-20.69%)
Updated
Sep 2 closing price
Capitalization
2.79M
Interact to see
Advertisement

VBIZF vs ZLDAF

Header iconVBIZF vs ZLDAF Comparison
Open Charts VBIZF vs ZLDAFBanner chart's image
Viva Biotech Holdings
Price$0.32
Change-$0.01 (-3.12%)
Volume$1.65K
Capitalization757.19M
Zelira Therapeutics
Price$0.23
Change-$0.06 (-20.69%)
Volume$100
Capitalization2.79M
VBIZF vs ZLDAF Comparison Chart in %
Loading...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VBIZF vs. ZLDAF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VBIZF is a Hold and ZLDAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (VBIZF: $0.31 vs. ZLDAF: $0.23)
Brand notoriety: VBIZF and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VBIZF: 30% vs. ZLDAF: 15%
Market capitalization -- VBIZF: $757.19M vs. ZLDAF: $2.79M
VBIZF [@Biotechnology] is valued at $757.19M. ZLDAF’s [@Biotechnology] market capitalization is $2.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VBIZF’s FA Score shows that 1 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • VBIZF’s FA Score: 1 green, 4 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, VBIZF is a better buy in the long-term than ZLDAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VBIZF’s TA Score shows that 3 TA indicator(s) are bullish while ZLDAF’s TA Score has 3 bullish TA indicator(s).

  • VBIZF’s TA Score: 3 bullish, 4 bearish.
  • ZLDAF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VBIZF is a better buy in the short-term than ZLDAF.

Price Growth

VBIZF (@Biotechnology) experienced а 0.00% price change this week, while ZLDAF (@Biotechnology) price change was -20.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.99%. For the same industry, the average monthly price growth was +10.86%, and the average quarterly price growth was +33.07%.

Industries' Descriptions

@Biotechnology (+1.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VBIZF($757M) has a higher market cap than ZLDAF($2.79M). VBIZF YTD gains are higher at: 344.288 vs. ZLDAF (-40.731).
VBIZFZLDAFVBIZF / ZLDAF
Capitalization757M2.79M27,103%
EBITDAN/A-3.17M-
Gain YTD344.288-40.731-845%
P/E Ratio37.50N/A-
RevenueN/A40.9K-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
VBIZF vs ZLDAF: Fundamental Ratings
VBIZF
ZLDAF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
78100
PRICE GROWTH RATING
1..100
3488
P/E GROWTH RATING
1..100
46100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VBIZF's Valuation (3) in the null industry is significantly better than the same rating for ZLDAF (94). This means that VBIZF’s stock grew significantly faster than ZLDAF’s over the last 12 months.

VBIZF's Profit vs Risk Rating (100) in the null industry is in the same range as ZLDAF (100). This means that VBIZF’s stock grew similarly to ZLDAF’s over the last 12 months.

VBIZF's SMR Rating (78) in the null industry is in the same range as ZLDAF (100). This means that VBIZF’s stock grew similarly to ZLDAF’s over the last 12 months.

VBIZF's Price Growth Rating (34) in the null industry is somewhat better than the same rating for ZLDAF (88). This means that VBIZF’s stock grew somewhat faster than ZLDAF’s over the last 12 months.

VBIZF's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for ZLDAF (100). This means that VBIZF’s stock grew somewhat faster than ZLDAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VBIZFZLDAF
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
48%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
76%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
50%
Bearish Trend 4 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
44%
Bearish Trend 4 days ago
70%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
64%
Aroon
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DODWX16.200.07
+0.43%
Dodge & Cox Global Stock I
HAOSX16.000.03
+0.19%
Harbor International Core Institutional
OSSIX24.050.04
+0.17%
Invesco Main Street Small Cap R6
MUXRX27.97-0.09
-0.32%
Victory S&P 500 Index R
MLMAX23.45-0.20
-0.85%
Morgan Stanley Instl Global Core A

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with CLDI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
CLDI - VBIZF
34%
Loosely correlated
+1.91%
SPHRY - VBIZF
11%
Poorly correlated
N/A
WXXWY - VBIZF
3%
Poorly correlated
+2.07%
UCBJF - VBIZF
3%
Poorly correlated
+7.45%
ZLDAF - VBIZF
2%
Poorly correlated
N/A
More

ZLDAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with BMEA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
N/A
BMEA - ZLDAF
37%
Loosely correlated
+4.92%
QLGN - ZLDAF
33%
Loosely correlated
+1.20%
SCNI - ZLDAF
32%
Poorly correlated
-3.85%
LYEL - ZLDAF
27%
Poorly correlated
+3.67%
YECO - ZLDAF
26%
Poorly correlated
N/A
More